Online inquiry

IVTScrip™ mRNA-Human AFAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK14378MR)

This product GTTS-WK14378MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AFAP1 protein. This product can be used in Brush cell (Tuft cell)-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001134647.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 60312
UniProt ID Q8N556
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AFAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK14378MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK19114MR IVTScrip™ mRNA-Human ANKRD28, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD28
GTTS-WK7735MR IVTScrip™ mRNA-Human ADGRD2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADGRD2
GTTS-WK28641MR IVTScrip™ mRNA-Human ARL4A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL4A
GTTS-WK12282MR IVTScrip™ mRNA-Human AFF1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AFF1
GTTS-WK19468MR IVTScrip™ mRNA-Human AOAH, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AOAH
GTTS-WK26819MR IVTScrip™ mRNA-Human ARHGEF39, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF39
GTTS-WK10102MR IVTScrip™ mRNA-Human ADAMTS2, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADAMTS2
GTTS-WK13701MR IVTScrip™ mRNA-Human ADAMTS17, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADAMTS17
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →